Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. (Q38027604)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 19 July 2012

Language	Label	Description	Also known as
English	Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.	scientific article published on 19 July 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

atopic dermatitis

1 reference

based on heuristic

inferred from title

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jacek Szepietowski

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

European Dermatology Forum

23

object named as

European Dermatology Forum

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

J Ring

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Alomar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Bieber

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M Deleuran

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Fink-Wagner

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Gelmetti

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

U Gieler

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

J Lipozencic

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Luger

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A P Oranje

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Schäfer

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Schwennesen

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Seidenari

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

D Simon

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

G Stingl

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Szalai

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Taïeb

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Werfel

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Wollenberg

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

U Darsow

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

European Academy of Dermatology and Venereology

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

European Task Force on Atopic Dermatitis

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

European Federation of Allergy

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

European Society of Pediatric Dermatology

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Global Allergy and Asthma European Network

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

19 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1176-1193

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Cutaneous sensory nerves: mediators of phototherapeutic effects?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Heliotherapy improves vitamin D balance and atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

What's new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2006 and 2007.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Targeted UVB-308 nm (NUVB) therapy with excimer laser in the treatment of atopic dermatitis and other inflammatory dermatoses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Management of atopic dermatitis using photo(chemo)therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

A pilot study showing pulsed-dye laser treatment improves localized areas of chronic atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

A randomized trial of methotrexate versus azathioprine for severe atopic eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Recombinant interferon gamma therapy for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Successful interferon alpha therapy in atopic dermatitis of Besnier's prurigo pattern with normal serum IgE and blood eosinophil fraction: randomized case-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Treatment of atopic eczema with oral alitretinoin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Alefacept for moderate to severe atopic dermatitis: a pilot study in adults.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Efalizumab for severe atopic dermatitis: a pilot study in adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Allergen-specific Immunotherapy in Atopic Eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Immunotherapy in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Complementary therapy for atopic eczema and other allergic skin diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

The essence of alternative medicine. A dermatologist's view from Germany.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Complementary medicine in Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Alternative medicine in allergies - prevalence, patterns of use, and costs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Gamma-linolenic-acid-rich borage seed oil capsules in children with atopic dermatitis. A placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Efficacy of dietary hempseed oil in patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Herbal therapy in dermatology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

A randomized, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Adverse effects of herbal drugs in dermatology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Stealth triamcinolone acetonide in a phytocosmetic cream

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Traditional Chinese medicine for the treatment of dermatologic disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Acupuncture, electrostimulation, and reflex therapy in dermatology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema - a blinded, randomized, placebo-controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Randomized, double-blind, placebo-controlled trial of autologous blood therapy for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Efficacy trial of bioresonance in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

The usage of complementary therapies by dermatological patients: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Homeopathic treatment of Japanese patients with intractable atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Atopic dermatitis symptoms decreased in children following massage therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Indications, contraindications and possible side‐effects of climatotherapy at the Dead‐Sea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Postnatal somatic and mental development after periconceptional multivitamin supplementation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Evaluation of dietary intake of vitamin E in the treatment of atopic dermatitis: a study of the clinical course and evaluation of the immunoglobulin E serum levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Topical vitamin B12--a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Evaluation of Topical Vitamin B12 for the Treatment of Childhood Eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Atopic dermatitis and psychological stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Pediatric atopic eczema: the impact of an educational intervention.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Structured education program improves the coping with atopic dermatitis in children and their parents-a multicenter, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Eczema workshops reduce severity of childhood atopic eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Three years of Italian experience of an educational program for parents of young children affected by atopic dermatitis: improving knowledge produces lower anxiety levels in parents of children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

A review of the impact and effectiveness of nurse-led care in dermatology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Substitution of doctors by nurses in primary care

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Cross-cultural development of a child health care questionnaire on satisfaction, utilization, and needs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Educational programmes for young people with eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

The information needs and preferred roles in treatment decision-making of parents caring for infants with atopic dermatitis: a qualitative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Involuntary autonomy: patients' perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

[A guide for education programs in atopic dermatitis].

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Compliance among patients with atopic eczema.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Written action plans: potential for improving outcomes in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

The status of Internet access in adult patients with atopic dermatitis in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Treatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse prevention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

Identifiers

10.1111/J.1468-3083.2012.04636.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38027604&oldid=1547431725"